AstraZeneca PLC/ GB0009895292 /
| 2024-04-16 5:23:54 PM | Chg. -8.75 | Volume | Bid5:25:00 PM | Ask5:25:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1,492.50SEK | -0.58% | 89,484 Turnover: 63.64 mill. |
-Bid Size: - | -Ask Size: - | 2283.84 bill.SEK | - | - |
Assets
|
2019 - in mill. USD |
2020 - in mill. USD |
2021 - in mill. USD |
2022 IFRS in mill. USD |
2023 IFRS in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 7,688 | 8,251 | 9,183 | 8,507 | 9,402 | ||||||
| Intangible Assets | 20,833 | 20,947 | 42,387 | 39,307 | 38,089 | ||||||
| Long-Term Investments | 61 | 171 | 102 | 76 | 1,677 | ||||||
| Fixed Assets | 45,814 | 47,185 | 79,119 | 73,890 | 76,065 | ||||||
| Inventories | 3,193 | 4,024 | 8,983 | 4,699 | 5,424 | ||||||
| Accounts Receivable | - | - | - | 7,271 | 12,126 | ||||||
| Cash and Cash Equivalents | 5,369 | 7,832 | 6,329 | 6,166 | 5,840 | ||||||
| Current Assets | 15,563 | 19,544 | 26,244 | 22,593 | 25,054 | ||||||
| Total Assets | 61,377 | 66,729 | 105,363 | 96,483 | 101,119 | ||||||
Liabilities
|
2019 - in mill. USD |
2020 - in mill. USD |
2021 - in mill. USD |
2022 IFRS in mill. USD |
2023 IFRS in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | - | - | - | 2,550 | 22,374 | ||||||
| Long-term debt | 18 | 2 | 45 | 23,690 | 22,365 | ||||||
| Liabilities to Banks | 1,876 | 2,229 | 1,784 | - | - | ||||||
| Provisions | 5,415 | 5,605 | 8,846 | 4,562 | 4,999 | ||||||
| Liabilities | 46,781 | 51,091 | 66,076 | 59,425 | 61,953 | ||||||
| Share Capital | 328 | 328 | 387 | - | - | ||||||
| Total Equity | 14,596 | 15,638 | 39,287 | 37,037 | 39,143 | ||||||
| Minority Interests | 1,469 | 16 | 19 | 21 | 23 | ||||||
| Total liabilities equity | 61,377 | 66,729 | 105,363 | 96,483 | 101,119 | ||||||
Income Statement
|
2019 - in mill. USD |
2020 - in mill. USD |
2021 - in mill. USD |
2022 IFRS in mill. USD |
2023 IFRS in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 24,384 | 26,617 | 37,417 | 44,351 | 45,811 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 2,924 | 5,162 | 1,056 | 3,757 | 8,193 | ||||||
| Interest Income | -1,260 | -1,219 | -1,257 | -1,251 | -1,282 | ||||||
| Income Before Taxes | 1,548 | 3,916 | -265 | 2,501 | 6,899 | ||||||
| Income Taxes | 321 | 772 | -380 | -792 | 938 | ||||||
| Minority Interests Profit | 108 | 52 | -3 | -5 | 6 | ||||||
| Net Income | 1,335 | 3,196 | 112 | 3,228 | 5,955 | ||||||
Per Share
Cash Flow
|
2019 - in mill. USD |
2020 - in mill. USD |
2021 - in mill. USD |
2022 IFRS in mill. USD |
2023 IFRS in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 2,969 | 4,799 | 5,963 | 9,808 | 10,345 | ||||||
| Cash Flow from Investing Activities | -657 | -285 | -11,058 | -2,960 | -4,064 | ||||||
| Cash Flow from Financing | -1,765 | -2,203 | 3,649 | -6,823 | -6,567 | ||||||
| Decrease / Increase in Cash | 547 | 2,311 | -1,446 | - | - | ||||||
| Employees | 70,600 | 76,100 | 83,100 | 83,500 | 89,900 | ||||||
